ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 223 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $249 | -34.3% | 6,247 | -23.8% | 0.00% | -50.0% |
Q4 2022 | $379 | -99.9% | 8,196 | +19.9% | 0.00% | +100.0% |
Q3 2022 | $282,000 | +36.9% | 6,836 | +96.9% | 0.00% | 0.0% |
Q2 2022 | $206,000 | -16.6% | 3,472 | +1.7% | 0.00% | 0.0% |
Q1 2022 | $247,000 | -15.4% | 3,414 | -2.0% | 0.00% | 0.0% |
Q4 2021 | $292,000 | +114.7% | 3,482 | +129.5% | 0.00% | 0.0% |
Q3 2021 | $136,000 | -8.7% | 1,517 | -3.4% | 0.00% | 0.0% |
Q2 2021 | $149,000 | -13.4% | 1,571 | +3.8% | 0.00% | 0.0% |
Q1 2021 | $172,000 | -69.3% | 1,513 | -62.7% | 0.00% | -75.0% |
Q4 2020 | $560,000 | +216.4% | 4,054 | +86.9% | 0.00% | +100.0% |
Q3 2020 | $177,000 | +7.3% | 2,169 | +2.6% | 0.00% | 0.0% |
Q2 2020 | $165,000 | +75.5% | 2,114 | 0.0% | 0.00% | +100.0% |
Q1 2020 | $94,000 | -14.5% | 2,114 | -18.0% | 0.00% | 0.0% |
Q4 2019 | $110,000 | -6.0% | 2,577 | -5.8% | 0.00% | -50.0% |
Q3 2019 | $117,000 | -34.3% | 2,737 | -2.4% | 0.00% | 0.0% |
Q2 2019 | $178,000 | +14.1% | 2,803 | +25.1% | 0.00% | 0.0% |
Q1 2019 | $156,000 | +69.6% | 2,241 | +5.9% | 0.00% | 0.0% |
Q4 2018 | $92,000 | -43.2% | 2,116 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $162,000 | -0.6% | 2,116 | 0.0% | 0.00% | -33.3% |
Q2 2018 | $163,000 | +50.9% | 2,116 | 0.0% | 0.00% | +50.0% |
Q1 2018 | $108,000 | – | 2,116 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
First Light Asset Management, LLC | 217,459 | $24,760,000 | 1.64% |
Motley Fool Asset Management LLC | 152,326 | $17,344,000 | 1.25% |
Rock Springs Capital Management LP | 450,000 | $51,237,000 | 1.12% |
AtonRa Partners | 21,017 | $2,393,000 | 1.07% |
SECTORAL ASSET MANAGEMENT INC | 112,200 | $12,775,000 | 0.97% |
EMERALD ADVISERS, LLC | 228,368 | $26,002,000 | 0.94% |
EMERALD MUTUAL FUND ADVISERS TRUST | 239,023 | $27,215,000 | 0.90% |
FEDERATED HERMES, INC. | 3,912,408 | $445,467,000 | 0.86% |
HealthCor Management, L.P. | 207,610 | $23,638,000 | 0.84% |
Atika Capital Management LLC | 66,000 | $7,515,000 | 0.65% |